These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 28012989

  • 21. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
    Sala M, Diab R, Elaissari A, Fessi H.
    Int J Pharm; 2018 Jan 15; 535(1-2):1-17. PubMed ID: 29111097
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin.
    Abdellatif AA, Tawfeek HM.
    AAPS PharmSciTech; 2016 Oct 15; 17(5):1067-74. PubMed ID: 26511937
    [Abstract] [Full Text] [Related]

  • 24. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
    Batheja P, Sheihet L, Kohn J, Singer AJ, Michniak-Kohn B.
    J Control Release; 2011 Jan 20; 149(2):159-67. PubMed ID: 20950659
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles.
    Küchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, Schäfer-Korting M, Kramer KD.
    Eur J Pharm Biopharm; 2009 Feb 20; 71(2):243-50. PubMed ID: 18796329
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
    Padois K, Cantiéni C, Bertholle V, Bardel C, Pirot F, Falson F.
    Int J Pharm; 2011 Sep 15; 416(1):300-4. PubMed ID: 21704140
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Novel alginate-based nanocarriers as a strategy to include high concentrations of hydrophobic compounds in hydrogels for topical application.
    Nguyen HT, Munnier E, Souce M, Perse X, David S, Bonnier F, Vial F, Yvergnaux F, Perrier T, Cohen-Jonathan S, Chourpa I.
    Nanotechnology; 2015 Jan 26; 26(25):255101. PubMed ID: 26033822
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
    Küchler S, Abdel-Mottaleb M, Lamprecht A, Radowski MR, Haag R, Schäfer-Korting M.
    Int J Pharm; 2009 Jul 30; 377(1-2):169-72. PubMed ID: 19439166
    [Abstract] [Full Text] [Related]

  • 36. Lipid nanoparticles for dermal drug delivery.
    Kakadia PG, Conway BR.
    Curr Pharm Des; 2015 Jul 30; 21(20):2823-9. PubMed ID: 25925115
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
    Thao le Q, Byeon HJ, Lee C, Lee S, Lee ES, Choi HG, Park ES, Youn YS.
    Int J Pharm; 2016 Jan 30; 497(1-2):268-76. PubMed ID: 26657273
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.